Drugs / ASC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03258164 | Mar 2017 → Oct 2022 | breasts and/or nipples, aplasia or hypoplasia of, 1 | Stemform | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03258164 ↗ |
| Modality | Cell therapy | “autologous ex vivo expanded ASC” NCT03258164 ↗ |
| Route | Other | “autologous ex vivo expanded ASC injected into the breast tissue or face” NCT03258164 ↗ |